ID

39498

Descrizione

Carbohydrate Antigen 125-guided Therapy in Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT02008110

collegamento

https://clinicaltrials.gov/show/NCT02008110

Keywords

versioni (1)
  1. 19/01/20 19/01/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

19 gennaio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Heart Failure NCT02008110

Inglese

Eligibility Heart Failure NCT02008110

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 years or older.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
at least 1 admission for ahf, in the last 180 days.
Descrizione

Admission Quantity Acute heart failure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0184666
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0264714
demonstrates functional new york heart association status of class ≥ii at the moment of enrollment.
Descrizione

New York Heart Association Classification

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1275491
objective evidence, either during the index admission or at least 180 days before enrollment, of a structural or functional abnormality of the heart at rest, and defined as: n terminal-pro-brain natriuretic peptide >1000 pg/ml or brain natriuretic peptide >100 pg/ml or echocardiographic abnormalities congruent with hf diagnosis such as: systolic left ventricular dysfunction (lvef <50%); left ventricular hypertrophy (defined as left ventricular septum or left ventricular posterior wall thickness ≥12 millimeters or left ventricular mass index >104 g/m2 in women or 116 g/m2 in men); ee`>15 or significant valvular heart disease (moderate-severe).
Descrizione

Structural Heart Abnormality | Cardiac function Abnormality At rest | N-Terminal ProB-type Natriuretic Peptide Measurement | Brain natriuretic peptide measurement | Echocardiography Abnormality Congruent Heart failure | Left ventricular systolic dysfunction | Left ventricular ejection fraction | Left Ventricular Hypertrophy | Left Ventricular septum Thickness | Inferior wall of left ventricle Thickness | Mass index of left ventricle | Gender | Heart valve disease Moderate | Heart valve disease Severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3274789
UMLS CUI [2,1]
C0232164
UMLS CUI [2,2]
C1704258
UMLS CUI [2,3]
C0443144
UMLS CUI [3]
C3272900
UMLS CUI [4]
C1095989
UMLS CUI [5,1]
C0013516
UMLS CUI [5,2]
C1704258
UMLS CUI [5,3]
C0439853
UMLS CUI [5,4]
C0018801
UMLS CUI [6]
C1277187
UMLS CUI [7]
C0428772
UMLS CUI [8]
C0149721
UMLS CUI [9,1]
C0225870
UMLS CUI [9,2]
C0443246
UMLS CUI [9,3]
C1280412
UMLS CUI [10,1]
C0504056
UMLS CUI [10,2]
C1280412
UMLS CUI [11]
C2059474
UMLS CUI [12]
C0079399
UMLS CUI [13,1]
C0018824
UMLS CUI [13,2]
C0205081
UMLS CUI [14,1]
C0018824
UMLS CUI [14,2]
C0205082
a plasma ca125 value >35 u/ml in a recent test evaluation (at least 30 days before enrollment, and preferably assessed before hospital discharge).
Descrizione

Increased plasma CA 125

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4476918
patient must be capable of understanding and signing an informed consent form.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
life expectancy <12 months due to other diseases different from hf.
Descrizione

Life Expectancy Due to Disease | Exception Heart failure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0012634
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0018801
having undergone a cardiac transplantation, coronary revascularization procedure (percutaneous coronary intervention and/or coronary artery bypass grafting) or cardiac valve replacement in the past 3 months.
Descrizione

Heart Transplantation | Coronary revascularisation | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery | Heart valve replacement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018823
UMLS CUI [2]
C0877341
UMLS CUI [3]
C1532338
UMLS CUI [4]
C0010055
UMLS CUI [5]
C0190173
angina pectoris higher than class ii (canadian cardiovascular society classification).
Descrizione

Angina Pectoris Canadian Cardiovascular Society classification

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0002962
UMLS CUI [1,2]
C1277207
pregnancy at the moment of enrollment.
Descrizione

Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
valvular heart disease already scheduled for surgical intervention.
Descrizione

Heart valve disease Scheduled Surgical intervention

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018824
UMLS CUI [1,2]
C0205539
UMLS CUI [1,3]
C0549433
severe chronic obstructive and/or restrictive pulmonary disease, requiring continuous oxygen administration.
Descrizione

Severe chronic obstructive pulmonary disease | Restrictive pulmonary disease severe chronic | Oxygen Therapy Continuous Required

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0730607
UMLS CUI [2,1]
C0877013
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0205191
UMLS CUI [3,1]
C0184633
UMLS CUI [3,2]
C0549178
UMLS CUI [3,3]
C1514873
serum creatinine level > 3 mg/dl or chronic renal insufficiency on dialysis treatment.
Descrizione

Creatinine measurement, serum | Chronic Kidney Insufficiency | Dialysis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0403447
UMLS CUI [3]
C0011946
patients receiving resynchronization therapy during the index admission.
Descrizione

Cardiac Resynchronization Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1167956
significant concurrent medical diseases including cancer or a history of cancer within 5 years of entering the screening period, endometriosis, cirrhosis, acute coronary syndrome within 6 months, uncontrolled hypertension, history of human immunodeficiency virus (hiv) infection, or a significant active infection.
Descrizione

Comorbidity | Malignant Neoplasms | History of cancer | Endometriosis | Liver Cirrhosis | Acute Coronary Syndrome | Uncontrolled hypertension | HIV Infection | Communicable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0006826
UMLS CUI [3]
C0455471
UMLS CUI [4]
C0014175
UMLS CUI [5]
C0023890
UMLS CUI [6]
C0948089
UMLS CUI [7]
C1868885
UMLS CUI [8]
C0019693
UMLS CUI [9]
C0009450
participating in another randomized study.
Descrizione

Study Subject Participation Status | Clinical Trial, Randomized

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0206034
Ritorna all'inizio della pagina

Similar models

Eligibility Heart Failure NCT02008110

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Admission Quantity Acute heart failure
Item
at least 1 admission for ahf, in the last 180 days.
boolean
C0184666 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0264714 (UMLS CUI [1,3])
New York Heart Association Classification
Item
demonstrates functional new york heart association status of class ≥ii at the moment of enrollment.
boolean
C1275491 (UMLS CUI [1])
Structural Heart Abnormality | Cardiac function Abnormality At rest | N-Terminal ProB-type Natriuretic Peptide Measurement | Brain natriuretic peptide measurement | Echocardiography Abnormality Congruent Heart failure | Left ventricular systolic dysfunction | Left ventricular ejection fraction | Left Ventricular Hypertrophy | Left Ventricular septum Thickness | Inferior wall of left ventricle Thickness | Mass index of left ventricle | Gender | Heart valve disease Moderate | Heart valve disease Severe
Item
objective evidence, either during the index admission or at least 180 days before enrollment, of a structural or functional abnormality of the heart at rest, and defined as: n terminal-pro-brain natriuretic peptide >1000 pg/ml or brain natriuretic peptide >100 pg/ml or echocardiographic abnormalities congruent with hf diagnosis such as: systolic left ventricular dysfunction (lvef <50%); left ventricular hypertrophy (defined as left ventricular septum or left ventricular posterior wall thickness ≥12 millimeters or left ventricular mass index >104 g/m2 in women or 116 g/m2 in men); ee`>15 or significant valvular heart disease (moderate-severe).
boolean
C3274789 (UMLS CUI [1])
C0232164 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C0443144 (UMLS CUI [2,3])
C3272900 (UMLS CUI [3])
C1095989 (UMLS CUI [4])
C0013516 (UMLS CUI [5,1])
C1704258 (UMLS CUI [5,2])
C0439853 (UMLS CUI [5,3])
C0018801 (UMLS CUI [5,4])
C1277187 (UMLS CUI [6])
C0428772 (UMLS CUI [7])
C0149721 (UMLS CUI [8])
C0225870 (UMLS CUI [9,1])
C0443246 (UMLS CUI [9,2])
C1280412 (UMLS CUI [9,3])
C0504056 (UMLS CUI [10,1])
C1280412 (UMLS CUI [10,2])
C2059474 (UMLS CUI [11])
C0079399 (UMLS CUI [12])
C0018824 (UMLS CUI [13,1])
C0205081 (UMLS CUI [13,2])
C0018824 (UMLS CUI [14,1])
C0205082 (UMLS CUI [14,2])
Increased plasma CA 125
Item
a plasma ca125 value >35 u/ml in a recent test evaluation (at least 30 days before enrollment, and preferably assessed before hospital discharge).
boolean
C4476918 (UMLS CUI [1])
Informed Consent
Item
patient must be capable of understanding and signing an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Life Expectancy Due to Disease | Exception Heart failure
Item
life expectancy <12 months due to other diseases different from hf.
boolean
C0023671 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0018801 (UMLS CUI [2,2])
Heart Transplantation | Coronary revascularisation | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery | Heart valve replacement
Item
having undergone a cardiac transplantation, coronary revascularization procedure (percutaneous coronary intervention and/or coronary artery bypass grafting) or cardiac valve replacement in the past 3 months.
boolean
C0018823 (UMLS CUI [1])
C0877341 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0010055 (UMLS CUI [4])
C0190173 (UMLS CUI [5])
Angina Pectoris Canadian Cardiovascular Society classification
Item
angina pectoris higher than class ii (canadian cardiovascular society classification).
boolean
C0002962 (UMLS CUI [1,1])
C1277207 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy at the moment of enrollment.
boolean
C0032961 (UMLS CUI [1])
Heart valve disease Scheduled Surgical intervention
Item
valvular heart disease already scheduled for surgical intervention.
boolean
C0018824 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C0549433 (UMLS CUI [1,3])
Severe chronic obstructive pulmonary disease | Restrictive pulmonary disease severe chronic | Oxygen Therapy Continuous Required
Item
severe chronic obstructive and/or restrictive pulmonary disease, requiring continuous oxygen administration.
boolean
C0730607 (UMLS CUI [1])
C0877013 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205191 (UMLS CUI [2,3])
C0184633 (UMLS CUI [3,1])
C0549178 (UMLS CUI [3,2])
C1514873 (UMLS CUI [3,3])
Creatinine measurement, serum | Chronic Kidney Insufficiency | Dialysis
Item
serum creatinine level > 3 mg/dl or chronic renal insufficiency on dialysis treatment.
boolean
C0201976 (UMLS CUI [1])
C0403447 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
Cardiac Resynchronization Therapy
Item
patients receiving resynchronization therapy during the index admission.
boolean
C1167956 (UMLS CUI [1])
Comorbidity | Malignant Neoplasms | History of cancer | Endometriosis | Liver Cirrhosis | Acute Coronary Syndrome | Uncontrolled hypertension | HIV Infection | Communicable Disease
Item
significant concurrent medical diseases including cancer or a history of cancer within 5 years of entering the screening period, endometriosis, cirrhosis, acute coronary syndrome within 6 months, uncontrolled hypertension, history of human immunodeficiency virus (hiv) infection, or a significant active infection.
boolean
C0009488 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C0455471 (UMLS CUI [3])
C0014175 (UMLS CUI [4])
C0023890 (UMLS CUI [5])
C0948089 (UMLS CUI [6])
C1868885 (UMLS CUI [7])
C0019693 (UMLS CUI [8])
C0009450 (UMLS CUI [9])
Study Subject Participation Status | Clinical Trial, Randomized
Item
participating in another randomized study.
boolean
C2348568 (UMLS CUI [1])
C0206034 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial